Related Experiment Videos
The argument for HIV-antibody testing in chemical dependence treatment programs
1Emory University School of Medicine, Section of Psychiatry, The Emory Clinic, Atlanta, Georgia 30322.
Journal of Psychoactive Drugs
|October 1, 1989
Summary
Human immunodeficiency virus (HIV) antibody testing is beneficial in chemical dependence treatment. Key elements include staff education, counseling, confidentiality, and accurate tests for patient care and infection prevention.
Area of Science:
- Addiction Medicine
- Infectious Disease
- Public Health
Background:
- Debate exists regarding human immunodeficiency virus (HIV) antibody testing for chemically dependent patients.
- Despite controversy, HIV testing offers significant clinical and therapeutic advantages within addiction treatment settings.
Purpose of the Study:
- To evaluate the clinical and therapeutic utility of HIV antibody testing in chemical dependence treatment programs.
- To outline essential prerequisites and justifications for implementing voluntary HIV testing in these programs.
Main Methods:
- Review of clinical guidelines and ethical considerations for HIV testing in vulnerable populations.
- Emphasis on prerequisites: staff education, comprehensive pre- and post-test counseling, result confidentiality, and accurate testing methodologies.
Main Results:
- Voluntary HIV testing facilitates appropriate medical evaluation and treatment for chemically dependent patients.
- Testing aids in preventing the spread of HIV infection and supports patients in managing a positive diagnosis.
- Individualized testing decisions, based on patient consent and health-related factors, are crucial.
Conclusions:
- Voluntary, informed consent is paramount; involuntary testing and mass screening are not ethically supported.
- Implementing HIV testing requires a structured approach focusing on patient autonomy and comprehensive support.
- HIV testing can be an integral component of holistic care in chemical dependence treatment.